Results 201 to 210 of about 500,404 (395)
Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT‐HF registry
European Journal of Heart Failure, EarlyView.Global patterns of polypharmacy after acute heart failure hospitalization. GDMT, guideline‐directed medical therapy; HF, heart failure. Aims
Polypharmacy, defined as the concurrent use of ≥5 medications, is prevalent among older adults with heart failure (HF).Wan Ting Tay, Tiew‐Hwa Katherine Teng, Wouter Ouwerkerk, John G.F. Cleland, Sean P. Collins, Christiane E. Angermann, Kenneth Dickstein, Ulf Dahlstrom, Anja Schweizer, Achim Obergfell, Kai‐Hang Yiu, Mathieu Ghadanfar, Mahmoud Hassanein, Qing‐Wen Ren, Wen‐Li Gu, Georg Ertl, Sergio V. Perrone, Gerasimos Filippatos, Carolyn S.P. Lam, Jasper Tromp +19 morewiley +1 more sourceContemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM‐HF registry
European Journal of Heart Failure, EarlyView.Medical therapy use across the left ventricular ejection fraction spectrum in the OPTIPHARM‐HF registry. ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; GDMT, guideline‐directed medical therapy; HF, heart failure; HFmrEF, heart failure with mildly reduced ejection ...Riccardo M. Inciardi, Maurizio Volterrani, Gianluigi Savarese, Muthiah Vaduganathan, Chiara Oriecuia, Carlo M. Lombardi, Cristina Gussago, Piergiuseppe Agostoni, Pietro Ameri, Giuseppe Armentaro, Chiara Arzilli, Nadia Aspromonte, Andrea Attanasio, Roberto Badagliacca, Lucia Barbieri, Pier Paolo Bocchino, Francesca Bursi, Matteo Cameli, Martino Canonero, Jeness S. Campodonico, Teresa Capovilla, Erberto Carluccio, Stefano Carugo, Vincenzo Castiglione, Dario Catapano, Manlio Cipriani, Michele Correale, Domenico D'Amario, Raffaele De Caterina, Gaetano M. De Ferrari, Emilia D'Elia, Luca Di Odoardo, Michele Emdin, Luigi Falco, Giulia Ferrante, Alessandra Fornaro, Paolo Fornaro, Gionata Guastamiglio, Marco Guazzi, Massimo Iacoviello, Massimo Imazio, Enrico Incaminato, Maria Teresa La Rovere, Sergio Leonardi, Marta Maccallini, Giulia E. Mandoli, Daniele Masarone, Marco Masetti, Alberto Mazzoni, Marta Mazzotta, Marco Merlo, Luigi Moschini, Filippo Novarese, Alberto Palazzuoli, Maria C. Pastore, Giuseppe Patti, Roberto F.E. Pedretti, Stefano Pidello, Massimo F. Piepoli, Giuseppe Pinto, Luciano Potena, Claudia Raineri, Filippo M. Rubbo, Mario Sabatino, Andrea Salzano, Angela Sciacqua, Michele Senni, Paolo Severino, Gianfranco Sinagra, Barbara Sposato, Stefano Taddei, Alessandro Valleggi, Carlo Vignati, Dario Vizza, Claudia Specchia, Giuseppe Rosano, Marco Metra, on behalf of the OPTIPHARM‐HF investigators, Marianna Adamo, Marilisa Ambrosio, Paolo Biagioli, Valeria Borelli, Natale Brunetti, Margherita Calcagnino, Giuseppe Caminiti, Francesco Canonico, Angelo Caporotondi, Velia Cassano, Ali Chraim, Valentina Codazzi, Giuliana Cimino, Francesco Clemenza, Giuditta Cuccuru, Giulia De Lio, Giandomenico Disabato, Marcello Divino, Salvatore D'Isa, Roberta Famiani, Enrica Fede, Letizia Fiòorentino, Alberto Foa', Paolo Fornaro, Noemi Furlotti, Nicolò Gallingani, Alberto Genova, Stefano Ghio, Federico Gobbi, Daniela Grassano, Lucia Guerisoli, Manuela Iseppi, Simona Leone, Ferdinando Loiacono, Valeria Luberto, Rossella Manai, Niccolò Manetti, Lina Manzi, Fabio Marsico, Francesco Maruca, Gabriele Masini, Irene Mattavelli, Ciro Mauro, Alberto Mazzoni, Marta Mazzotta, Pierre Meynet, Valentina Morsella, Giulia Nemola, Martina Niccolai, Savina Nodari, Matteo Pagnesi, Gianpaolo Palmieri, Alberto Panza, Francesca Parisi, Carlo Alberto Pastura, Anna Lisa Picerni, Riccardo Pilia, Ilaria Pirrone, Nicola R. Pugliese, Claudio Puteo, Federica Ramani, Gloria Santangelo, Laura Scelsi, Edoardo Sciatti, Lorenza Sforzini, Giulia Spoto, Davide Stolfo, Roberto Tarantini, Maria Cristina Tavera, Floriana Tortomasi, Eduardo Valente, Giuseppe Varricchione, Enrico Vizzardi, Greta Zagni, Mattia Zampieri +152 morewiley +1 more sourceUrinary markers in heart failure – types, timing and thresholds. European Journal of Heart Failure expert consensus document
European Journal of Heart Failure, EarlyView.Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.Masatake Kobayashi, Biykem Bozkurt, Peder Langeland Myhre, Juan Carlos Lopez Azor, Mateusz Guzik, Gracjan Iwanek, Guillaume Baudry, Marta Cobo‐Marcos, Òscar Miró, Jeroen Dauw, Piotr Ponikowski, Wilfried Mullens, Alberto Palazzuoli, Marco Metra, Jan Biegus +14 morewiley +1 more sourcePharmacological treatment for patients with obesity and heart failure: Focus on glucagon‐like peptide‐1 receptor agonists. European Journal of Heart Failure expert consensus document
European Journal of Heart Failure, EarlyView.There is growing clinical interest in strategies for improving clinical outcomes in patients with heart failure (HF) and obesity. The development of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and of the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 RA has expanded therapeutic options for this population. This expert consensus Luca Monzo, Gianluigi Savarese, Wilfried Mullens, Amr Abdin, Biykem Bozkurt, Ovidiu Chioncel, Seif El Hadidi, Thomas M. Gorter, Riccardo M. Inciardi, Mark C. Petrie, Gabriele G. Schiattarella, Davide Stolfo, Marco Metra, Nicolas Girerd +13 morewiley +1 more source
